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Objectives: To investigate the effects of perorally administered juice on tetrachloro-
methane (CCl4)-induced hepatotoxicity model in rats.
Methods: Male Wistar rats were tube-administrated silymarin, Ecballium juice at
0.2 mL/kg and 0.7 mL/kg daily for 3 consequent days, i.e., 3.28 mg and 11.48 mg of
cucurbitacin B per kg of body weight respectively. On the third day, liver damage was
induced by intraperitoneal application of CCl4. On the fourth day, abdominal cavity was
macroscopically examined and liver samples were taken for histopathological and
immunochemical evaluation. HPLC was used to determine the content of the active
substance cucurbitacin B.
Results: The experiment revealed that 0.7 ml/kg juice concentration expressed the
highest pro-apoptotic activity, but with prevailing negative effects. Compared with the
lower concentration, there was an observable vasodilatation with consequent interstitial
hemorrhages and a larger scope of inﬂammatory damage, which suppressed the hep-
atoprotective effect. In the 0.2 mL/kg concentration, there was a smaller pro-apoptotic
activity but other parameters had better results, and the liver parenchyma damage was
reversible.
Conclusions: No reactions conﬁrming the potentially allergic effect on laboratory rats
were observed; its hepatoprotective and anti-inﬂammatory effect was conﬁrmed on a
model of acute liver damage.1. Introduction
Natural remedies for the prevention and therapy of liver
diseases have been popular worldwide in the traditional medi-
cine; however, there is a limited amount of information on their
biological activity. To date, there have been many experimental
studies utilizing in vitro or in vivo animal models, which provide
basic information on the effect and possible toxicity, necessary
for further stages of clinical evaluation. Hepatoprotective drugsused in classical medicine have their origin in plant extracts e.g.,
silymarin from Silybum marianum (milk thistle).
Ecballium elaterium (L.) (E. elaterium) A. Rich (squirting
cucumber) is a wild-growing herb from family Cucurbitacae,
which is abundant in the Mediterranean. Its fruits contain black
seeds and juice, which has been used in the Mediterranean re-
gions as a natural remedy for several indications, especially as
an analgesic, antipyretic and antiphlogistic [1]. In Anatolia
region, fresh juice has been a favourite drug for the treatment
of rhinosinusitis [2]. Anti-inﬂammatory effect of an aqueous
extract from E. elaterium for this indication was conﬁrmed in a
rabbit model [3].
The juice contains a broad spectrum of biologically active
substances [4]. The main active anti-inﬂammatory substance with
a conﬁrmed curative and preventive effect on tetrachloro-
methane (CCl4)-induced blood damage is cucurbitacin B, aopen access article under the CC BY-NC-ND
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decrease of bilirubin levels in blood was experimentally
demonstrated in animals suffering from hepatitis [6]. The
impact of cucurbitacin on the levels of free and conjugated
plasma bilirubin in humans with normal or increased
bilirubinemia was proved by Greige-Gerges et al. [7].
During a pre-clinical experiment, the hepatoprotective ac-
tivity of squirting cucumber juice was conﬁrmed on
tetrachloromethane-induced liver damage model in laboratory
rats [8]. However, when administering concentrated juice, there
was reported several adverse effects. Based on the application
route and the dose, there were reported ADRs such as mucosa
irritation, pharyngeal edema, hypersalivation, dysphagia,
vomiting, conjunctivitis and corneal edema and erosion [1].
2. Materials and methods
2.1. Juice preparation
The green mature fruits of E. elaterium were collected from
El-Dabaa, located in the western desert of Egypt, in August
2011. The juice was squeezed from the fruits and then ﬁltered
twice through 0.45 mm membrane ﬁlter. This procedure yielded
a clear crude fruit juice, that was conserved and stored in sterile
tubes at −20 C.
2.2. Study design
This experiment was approved by the Animal Welfare and
Protection Committee of the University of Veterinary and
Pharmaceutical Sciences Brno. Male Wistar rats (AnLab, Czech
Republic) weighing on average (275 ± 25) g were divided into 5
groups, 10 animals each. A preventive medication was imple-
mented for the purposes of this study. Group Ⅰ was used as a
negative control, group Ⅱ as a positive control, which was
administered only CCl4. Groups Ⅲ–Ⅴ were tube-administered
the tested substance in total inhalation anesthesia (Isoﬂuran®,
Nicholas Piramal India) daily for 3 consequent days-group III
received standard comparative hepatoprotective drug silymarin,
i.e., a mixture of silybinin, silydianin and silychristin 1:1:1
(Sigma–Aldrich, Czech Republic) at 20 mg/kg po.; groupⅣ was
administered Ecballium juice at 0.2 mL/kg po.; and group Ⅴ
juice at 0.7 mL/kg po. To achieve the hepatotoxic effect of the
used anesthetics and the results' comparability, even the animals
from the intact group were anesthetized. On the third day of the
experiment, animals from groups Ⅱ–Ⅴ were induced liver
damage by intraperitoneal application of 30% tetrachloro-
methane (Sigma–Aldrich, Czech Republic) suspended in olive
oil at 1 mL/kg. On the fourth day of the experiment, animals
were euthanized by cervical dislocation in total inhalation
anesthesia. During the consequent necropsy, abdominal cavity
was visually examined and liver tissue samples were taken for
histopathological and immunochemical evaluation. Tissue sec-
tions were formalin-ﬁxed, processed by standard histological
procedures and hematoxylin and eosin stained. For the immu-
nohistochemical examination, detection of fragmented DNA
(TUNEL assay) during the early and intermediate stages of
apoptosis was implemented. Biochemical examination was car-
ried out by a Dimension Sysmex RxR analyzer and data were
statistically evaluated by ANOVA-Tukey-HSD multiple com-
parison test by Unistat 5.1 software.2.3. HPLC analysis
The HPLC system HP 1100 series (Agilent Technologies,
Germany), equipped with the ChemStation software (Agilent
Technologies) and comprised a binary high-pressure pump, an
online vacuum degasser, an auto-sampler, a thermostated column
compartment and a multi wavelength detector set at 230 nm, was
used for the chromatographic analysis. The separations were
carried out on a Zorbax XDB-C18 column (50 mm × 2.1 mm i.d.,
1.7 mm particle size) fromAgilent Technologies. Gradient elution
starting from 10% of acetonitril and 90% of aqueous formic acid
(0.2%) was used. End of the gradient (pure acetonitril) was at
36 min. The ﬂow rate of mobile phase was set at 0.3 mL/min. The
injection volume was 10 mL, and the column temperature was
maintained at 30 C. The method based on external standard was
used for quantiﬁcation of cucurbitacin B. The content of the active
substance cucurbitacin B in juice was determined by HPLC at
16.4 mg/mL, so groupⅣ received 3.28 mg and group Ⅴ 11.48 mg
of cucurbitacin B per kg of body weight.
2.4. Monitored parameters
Biochemical examination included the determination of total
protein, albumin, bilirubin, alkaline phosphatase, alanine
aminotransferase, aspartate aminotransferase, cholesterol and
triacylglycerols in blood plasma.
The following histopathological characteristics were moni-
tored: mixed steatosis, zonal and focal necrosis, epitheloid–
granulomatous reaction, portal reaction, hepatocyte degenera-
tion, Kupffer cell activity, vasodilatation, interstitial hemor-
rhage, ﬁbrosis, polynuclear and macronuclear hepatocytes and
cholestasis. The morphological parameters were semi-




Table 1 summarizes the results of the biochemical exami-
nation. Total protein concentration in Ecballium 0.7 mL/kg was
highly signiﬁcantly greater and albumin concentration signiﬁ-
cantly greater compared to the negative control. Total bilirubin
concentrations in silymarin and Ecballium groups (both 0.2 mL/
kg and 0.7 mL/kg) were highly signiﬁcantly greater when
compared with the negative control group. The catalytic activity
of aspartate aminotransferase was signiﬁcantly greater in the
silymarin group and highly signiﬁcantly greater in Ecballium
0.2 mL/kg and 0.7 mL/kg groups when compared with the
control. Cholesterol and triacylglycerols concentrations in the
positive control, silymarin and both Ecballium groups were
highly signiﬁcantly higher when compared with the control.
3.2. Histopathological evaluation
Semiquantitative histopathological evaluation of the liver
parenchyma is given in Table 2. Intact control revealed damage,
which corresponded to the effect of total isoﬂurane anesthesia,
i.e., dilated veins with hemorrhages, reactive reactions in por-
tobiliary space, microvesicular steatosis in their vicinity and
increased activity of Kupffer cells (Figure 1A).
Table 1

















Ecballium 0.2 mL/kg 62.21 ± 3.16 37.68 ± 1.27 3.22 ± 0.64** 4.23 ± 0.51 2.81 ± 1.11 11.89 ± 3.69** 1.40 ± 0.32** 0.41 ± 0.17**
Ecballium 0.7 mL/kg 66.60 ± 2.98** 39.48 ± 1.51* 2.75 ± 0.42** 4.45 ± 0.77 3.15 ± 2.69 11.19 ± 4.41** 1.49 ± 0.14** 0.64 ± 0.34**
Positive control 61.80 ± 2.65 37.34 ± 2.46 2.52 ± 0.62 3.88 ± 1.18 1.49 ± 0.62 6.99 ± 1.80 1.44 ± 0.09** 0.79 ± 0.53**
Silymarin 20 mg/kg 62.62 ± 2.50 38.33 ± 1.90 2.94 ± 1.16** 4.43 ± 0.86 3.63 ± 3.23 9.40 ± 4.61* 1.46 ± 0.32** 0.64 ± 0.40**
Negative control 58.42 ± 4.60 36.55 ± 2.44 1.33 ± 0.14 5.15 ± 0.93 1.18 ± 0.52 3.77 ± 1.00 0.92 ± 0.12 1.89 ± 0.80













Mixed steatosis 4 4 4 4 5
Zonal and focal necrosis 2 3 4 3 0
Epitheloid–granulomatous reaction 4 5 4 4 0
Portal reaction 2 4 2 2 3
Hepatocyte degeneration 2 2 4 2 0
Kupffer cell activity 7 7 3 7 3
Vasodilatation 5 7 4 4 1
Interstitial hemorrhage 0 3 0 0 0
Fibrosis 2 3 2 2 2
Polynuclear and macronuclear hepatocytes 0 0 0 0 0
Cholestasis 0 1 0 0 0
Semiquantitative evaluation of the changes in liver parenchyma (0 = no changes, 10 = maximum changes).
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chloromethane, there were observed changes, which are typical
for CCl4-induced liver damage-venous dilatation with hemo-
stasis, necrotic hepatocytes present primarily in the area around
central veins and in the foci of damaged hepatocytes with
polymorphonuclear inﬁltration. The necrosis was accompanied
by inﬂammatory reaction with granulomatous aggregation sur-
rounded by perivenular macrovesicular steatosis. Portobiliary
space was slightly reactive with dilated veins (Figure 1B).
In the group, which was administered a conventional hep-
atoprotective silymarin, there were observed reactive changes,
steatotic and partially also necrotic cells in the liver parenchyma,
scavenging reaction around the central vein, uncircumscribed
portobiliar space, and generally greater inﬂammatory reaction
than in groups administered the tested juice. CCl4-induced liver
damage after the administration of silymarin was smaller, yet,
hepatocytes necrosis, macrovesicular steatosis, granulomatous
inﬂammatory reaction and dilated central veins were present in
the perivenous area of the liver parenchyma (Figure 1C).
The group administered Ecballium at 0.2 mL/kg was histo-
pathologically characterized by persistent inﬂammatory reaction
manifested by granulomatous aggregates. However, there was
apparent reduction of perivenular macrovesicular steatosis and
necrosis of hepatocytes with regenerative processes (Figure 1D).
In the 0.7 mL/kg concentration group, there was, in com-
parison with the lower concentration group, a visible dilatation
of central veins and larger scope of inﬂammatory and necrotic
tissue damage, which suppressed hepatoprotective effect of the
administered substance (Figure 1E).
3.3. Apoptosis evaluation (TUNEL)
In the negative control group, no apoptotic changes in he-
patocytes were observed (Figure 2A). Similar results were alsofound in the positive control group, liver parenchyma did not
contain apoptotic cells (Figure 2B). It can therefore be stated that
CCl4 induces especially necrotic death of hepatocytes. In the
silymarin group, there were observed positive apoptotic cells,
but in a smaller amount than in the Ecballium groups
(Figure 2C). Apoptosis of hepatocytes is induced by both
Ecballium juice concentrations. The greatest number of
apoptotic hepatocytes was found in liver of rats, which were
administered the 0.7 mL/kg concentration juice (Figure 2E). In
the 0.2 mL/kg group, apoptotic cells were observed in smaller
amounts (Figure 2D). It can be therefore supposed that quantity
of apoptotic cells probably correlates with the extract
concentration.
4. Discussion
During the experiment, CCl4 was used to induce an acute
liver damage. Tetrachloromethane biotransformation leads to
the production of highly reactive free radical metabolites,
which causes lipid peroxidation and damage to hepatocyte
membranes, leading to centrilobular necrosis of hepatocytes
accompanied by lipid degeneration [9]. Neutrophils cumulate
around the damaged hepatocytes, and they induce
inﬂammatory reaction through pro-inﬂammatory cytokines
(TNF-a, IL-1 and IL-6) [10]. Based on the CCl4 concentration,
there can be a different degree of liver damage [11]. Single dose
administration results in a centrilobular necrosis and steatosis,
long-term administration causes liver ﬁbrosis, cirrhosis and
hepatocellular carcinoma [12].
Some studies imply that tetrachloromethane induces not only
necrosis, but it can also initiate hepatocytes apoptosis [13–15].
Wu et al. [15] in their study verifying the hepatoprotective
effect of echinacoside reported an increased number of
apoptotic hepatocytes in the group exposed to CCl4, compared
Figure 1. Histopathological result of liver parenchyma.
HE stain, magniﬁcation 200×.
A: Negative control, dilated veins with hemorrhages, reactive reactions in portobiliary space, microvesicular steatosis in their vicinity and increased activity
of Kupffer cells.
B: Positive control, venous dilatation with hemostasis, necrotic hepatocytes present primarily in the area around central veins and in the foci of damaged
hepatocytes with polymorphonuclear inﬁltration. The necrosis with inﬂammatory reaction and granulomatous aggregation surrounded by perivenular
macrovesicular steatosis. Portobiliary space slightly reactive with dilated veins.
C: Silymarin, reactive changes, scavenging reaction around the central vein, uncircumscribed portobiliar space. Hepatocytes necrosis, macrovesicular
steatosis, granulomatous inﬂammatory reaction and dilated central veins in the perivenous area of the liver parenchyma.
D: Ecballium 0.2 mL/kg, persistent inﬂammatory reaction manifested by granulomatous aggregates. Apparent reduction of perivenular macrovesicular
steatosis and necrosis of hepatocytes with regenerative processes.
E: Ecballium 0.7 mL/kg, dilatation of central veins with extensive inﬂammatory and necrotic tissue damage.
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that CCl4 causes apoptosis of hepatocytes through the caspase-3
activation, which is released due to a secondary necrosis, which
occurs in liver simultaneously with apoptosis.
Animals were totally anesthetized prior to the administration
of tested substances. All animals were anesthetized due to iso-
ﬂurane hepatotoxicity, therefore even the negative control
revealed anticipated changes of the liver tissue – diffuse
microvesicular steatosis as a reaction to anesthesia. Isoﬂurane
hepatotoxicity is mediated by its metabolites, which cause in-
hibition of beta-oxidation and respiratory processes in the
mitochondria in hepatocytes [16].
There is not enough relevant data on the hepatoprotective
effect of E. elaterium. To date, there is only a study by Agil et al.
[8], which focused on the hepatoprotective effect of elateriumand cucurbitacin B isolated from the juice. The study
implemented a model of CCl4-induced hepatotoxicity, test
animals were mice and laboratory rats, and silymarin was used
as a comparative standard hepatoprotective substance. The
study tested both prophylactic and therapeutic administration
of these substances. Preventive administration of elaterium and
cucurbitacin B revealed a substantial reduction of CCl4-
induced lesions. Necrosis was observed only in some
hepatocytes and the steatosis stage was lower.
Correspondingly, the therapeutic administration of these
substances had a very favorable effect; the steatosis scope was
reduced and inﬂammation eliminated. Liver of animals
exposed only to CCl4 revealed stage 4 steatosis and
inﬂammatory reaction. Results imply that the hepatoprotective
signiﬁcance of Ecballium is probably caused by cucurbitacins,
Figure 2. TUNEL result of liver parenchyma.
TUNEL, magniﬁcation 200×.
A: Negative control, no apoptotic changes in hepatocytes.
B: Positive control, necrotic hepatocytes, no apoptotic changes in hepatocytes.
C: Silymarin, apoptotic cells (1), dilated central vein (2) macrovesicular steatosis (3) with granulomatous reaction (4).
D: Ecballium 0.2 mL/kg, apoptotic cells (1), dilated central vein (2) and necrotic hepatocytes (3).
E: Ecballium 0.7 mL/kg, Apoptotic cells (1), dilated central vein (2).
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contained in the juice can participate on this effect.
Older studies by Yesilada et al. [17] identiﬁed cucurbitacin B
as the main anti-inﬂammatory substance of Ecballium using an
in vivo model of increased venous permeability. Other cucur-
bitacins in Ecballium, i.e., cucurbitacin E, I and D, were found
ineffective in this indication. Cucurbitacin B also revealed
inhibitory activity on a model using bradykinin- and serotonin-
induced edema of mice paws [18].
During the experiment, there was also evaluated the overall
effect of the juice on rats’ organisms and the possible devel-
opment of adverse effects. Serious irritation to the mucosa is a
common adverse effect of Ecballium juice, which usually oc-
curs, if it is used undiluted. Eken et al. [19] described a case
study, where a patient experienced uvular edema and nasal
mucosa necrosis after an intranasal administration of undiluted
juice. The absence of systemic side effects, minimum impact
of standard antiallergic therapy and mucosa necrosis support
the non-allergic core of the reaction. No animal showed sys-
temic reaction after the administration of tested substances.The direct toxic effect is also reported by a study representing
a group of patients, who were exposed to the effect of undiluted
juice. They experienced a serious form of mucosa irritation,
which was manifested by pharynx edema, breathlessness,
dysphagia, vomiting or conjunctivitis, depending on the method
of administration of the undiluted juice (oral, intranasal, dermal
or ocular). In the end, it was stated that the exposure to undiluted
juice causes inﬂammatory irritation of mucosa and the anti-
inﬂammatory effect results from the application of optimum
juice concentration [1]. This implication was also conﬁrmed by a
report by Sezik and Yesilada, who stated that the degree of juice
dilution represents a criterion of its toxicity [20].
As for the pro-apoptotic effect of E. elaterium juice, there is
not enough information. To date, there have only been studies
focused on the research of pro-apoptotic effect of cucurbitacin B
in connection with its antitumor effect, which was successfully
tested on several tumor types (e.g., tumors of breast, larynx and
pancreas), both individually and in combination with commer-
cially available cytostatics [21–23]. Its effect was also conﬁrmed
in hepatocellular carcinoma (HCC). Experiments were carried
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B resulted in the termination of tumor cells growth in the S-
phase of cell cycle and induction of apoptosis, evidenced by
the presence of characteristic morphological changes. The
effect is dose-dependent and attributed to STAT3 suppression
and transcription factor regulating expression of genes, which
participate in the proliferation, apoptosis suppression and
angiogenesis [24,25]. Another conﬁrmed antitumor mechanism
lies in the modiﬁcation of Raf-MEK-ERK signaling pathway
(c-Raf suppression and ERK1/2 activation), which plays an
important role in the cell proliferation, differentiation and
apoptosis, and its dysregulation results in carcinogenesis. An
increased c-Raf expression was observed in spontaneously
developing HCC [25].
TUNEL assay methods proved pro-apoptotic activity of E.
elaterium juice. Pro-apoptotic effect is a manifestation of its
hepatoprotective effect, because hepatocytes apoptosis is not a
process of a group necrosis of cells, and usually it is not
accompanied by inﬂammatory reaction. Potentially necrotic cells
become apoptotic, which results in the reduction of inﬂamma-
tory reaction and the degree of liver parenchyma necrosis.
The experiment revealed that 0.7 mL/kg juice concentration
expressed the highest pro-apoptotic activity, but with prevailing
negative effects. Compared with the lower concentration, there
was observable a signiﬁcant vasodilatation with consequent
interstitial hemorrhages and also a larger scope of inﬂammatory
damage, which suppressed the hepatoprotective effect. In the
0.2 mL/kg concentration, there was a smaller pro-apoptotic ac-
tivity but other parameters had better results, and the liver pa-
renchyma damage was reversible. Based on these results, its
hepatoprotective effect was conﬁrmed on a model of acute liver
damage. This effect can be beneﬁcial in clinical practice.
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